Fidaxomicin
- TRADE NAME: Dificid (Optimer)
- INDICATIONS: Clostridium difficile associated diarrhea
- CLASS: Antibiotic, Antibiotic; macrolide, Antimicrobial
- HALF-LIFE: 1–5 hours
FDA APPROVAL DATE: 05/27/2011
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:None known
PREGNANCY CATEGORY: B
Please login to see the rest of this drug profile
SKIN.
ENDOCRINE/METABOLIC.
GASTROINTESTINAL/HEPATIC.
HEMATOLOGIC.
OTHER.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric